American Journal of Infectious Diseases and Microbiology
ISSN (Print): 2328-4056 ISSN (Online): 2328-4064 Website: Editor-in-chief: Maysaa El Sayed Zaki
Open Access
Journal Browser
American Journal of Infectious Diseases and Microbiology. 2016, 4(1), 14-21
DOI: 10.12691/ajidm-4-1-3
Open AccessArticle

Predictors of Tuberculosis Treatment Outcome in an Urban Setting: A Retrospective Cohort Study

Hema Darshinee Johnson1, Mano Raj Dayalan1, Chin Cheau Wei1, Ganesh Kasinathan2, , Parasakthi Navarathnam1 and Naganathan Pillai1

1Monash University Malaysia, Johor Bahru, Johor, Malaysia

2Department of Internal Medicine, Segamat Hospital, KM 6 Jalan Genuang, 85000 Segamat, Johor, Malaysia

Pub. Date: March 03, 2016

Cite this paper:
Hema Darshinee Johnson, Mano Raj Dayalan, Chin Cheau Wei, Ganesh Kasinathan, Parasakthi Navarathnam and Naganathan Pillai. Predictors of Tuberculosis Treatment Outcome in an Urban Setting: A Retrospective Cohort Study. American Journal of Infectious Diseases and Microbiology. 2016; 4(1):14-21. doi: 10.12691/ajidm-4-1-3


This is a retrospective cohort study on tuberculosis in 286 patients aged between 18-60 years who had completed anti-tuberculosis treatment for a minimum of six months for patients diagnosed with pulmonary tuberculosis and nine months for patients diagnosed with extra-pulmonary tuberculosis in an out-patient government clinic in Johor Bahru. Patients were analysed by age group, gender, ethnicity, occupation, types of tuberculosis, smear results, presenting chest X-Ray, presenting clinical symptoms, duration of symptoms, comorbidities and relevant social history. Treatment outcomes of patients were assessed based on clinical symptoms resolution, chest x-ray resolution and smear clearance at two months, four months and six months after commencement of treatment. The data was analyzed using SPSS version 16.0. Male gender, weight loss, night sweats, moderate to severe chest X-Ray findings, involvement of both lungs, smear positivity and smoking history were significant predictors of poor anti-tuberculosis treatment outcomes. On the other hand, smear negativity is a significant predictor of good treatment outcomes. Males, middle aged groups, ethnicity, lower social status and homemakers were at a higher risk of developing tuberculosis and thus further studies on these population groups are required..

retrospective tuberculosis predictors treatment outcomes

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Organization, W.H., Global tuberculosis report 2013. 2013: World Health Organization.
[2]  Gomes, T., et al., Extrapulmonary tuberculosis: Mycobacterium tuberculosis strains and host risk factors in a large urban setting in Brazil. PloS one, 2013. 8(10): p. e74517.
[3]  Gupta, S., et al., Diabetes mellitus and HIV as co-morbidities in tuberculosis patients of rural south India. Journal of infection and public health, 2011. 4(3): p. 140-144.
[4]  Wang, Q., et al., Screening and intervention of diabetes mellitus in patients with pulmonary tuberculosis in poverty zones in China: Rationale and study design. Diabetes research and clinical practice, 2012. 96(3): p. 385-391.
[5]  Pednekar, M.S. and P.C. Gupta, Prospective study of smoking and tuberculosis in India. Preventive medicine, 2007. 44(6): p. 496-498.
[6]  Abdul-Rahman, H., et al., Negative impact induced by foreign workers: Evidence in Malaysian construction sector. Habitat International, 2012. 36(4): p. 433-443.
[7]  Atif, M., et al., Treatment outcome of new smear positive pulmonary tuberculosis patients in Penang, Malaysia. BMC infectious diseases, 2014. 14(1): p. 399.
[8]  Low, C.-T., et al., Exploring tuberculosis by types of housing development. Social Science & Medicine, 2013. 87: p. 77-83.
[9]  Augusto, C.J., et al., Characteristics of tuberculosis in the state of Minas Gerais, Brazil: 2002-2009. Jornal Brasileiro de Pneumologia, 2013. 39(3): p. 357-364.
[10]  Dye, C., et al., Trends in tuberculosis incidence and their determinants in 134 countries. Bulletin of the World Health Organization, 2009. 87(9): p. 683-691.
[11]  Berhe, G., F. Enquselassie, and A. Aseffa, Treatment outcome of smear-positive pulmonary tuberculosis patients in Tigray Region, Northern Ethiopia. BMC public health, 2012. 12(1): p. 537.
[12]  Muñoz-Sellart, M., et al, Factors associated with poor tuberculosis treatment outcome in the Southern Region of Ethiopia. The International Journal of Tuberculosis and Lung Disease, 2010. 14(8): p. 973-979.
[13]  Reis-Santos, B., et al., Socio-Demographic and Clinical Differences in Subjects with Tuberculosis with and without Diabetes Mellitus in Brazil–A Multivariate Analysis. PloS one, 2013. 8(4): p. e62604.
[14]  Bhattacharya, M.K., et al., Pulmonary tuberculosis among HIV seropositives attending a counseling center in Kolkata. Indian journal of public health, 2011. 55(4): p. 329.
[15]  Jiménez-Corona, M.E., et al., Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax, 2013. 68(3): p. 214-220.
[16]  Baker, M.A., et al., The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC medicine, 2011. 9(1): p. 81.
[17]  Dooley, K.E. and R.E. Chaisson, Tuberculosis and diabetes mellitus: convergence of two epidemics. The Lancet infectious diseases, 2009. 9(12): p. 737-746.
[18]  Sbrana, E., et al., Co-morbidities associated with tuberculosis in an autopsy case series. Tuberculosis, 2011. 91: p. S38-S42.
[19]  Nantha, S., A Review of Tuberculosis Research in Malaysia. Med J Malaysia, 2014. 69: p. 88.
[20]  Alcaide, J., et al., Cigarette smoking as a risk factor for tuberculosis in young adults: a casecontrol study. Tubercle and Lung Disease, 1996. 77(2): p. 112-116.
[21]  Nissapatorn, V., et al., Extrapulmonary tuberculosis in Peninsular Malaysia: retrospective study of 195 cases. Southeast Asian Journal of Tropical Medicine and Public Health, 2004. 35(2): p. 39-45.
[22]  Hayati, I.N., Y. Ismail, and Y. Zurkurnain, Extrapulmonary tuberculosis: a two-year review of cases at the General Hospital Kota Bharu. Med J Malaysia, 1993. 48(4): p. 417.
[23]  23.Centre_for_Disease_Control, Chapter 6: Treatment of Tuberculosis Disease, in Core Curriculum on Tuberculosis: What the Clinician Should Know. 2013. p. 139-187.
[24]  Saukkonen, J.J., K. Powell, and J.A. Jereb, Monitoring for tuberculosis drug hepatotoxicity: moving from opinion to evidence. American journal of respiratory and critical care medicine, 2012. 185(6): p. 598-599.
[25]  Gelband, H., Regimens of less than six months for treating tuberculosis. Cochrane Database of Systematic Reviews, 1999. 4.
[26]  Swaminathan, S., et al., Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial. American journal of respiratory and critical care medicine, 2010. 181(7): p. 743-751.
[27]  Pefura-Yone, E.W., A.P. Kengne, and C. Kuaban, Non-conversion of sputum culture among patients with smear positive pulmonary tuberculosis in Cameroon: a prospective cohort study. BMC infectious diseases, 2014. 14(1): p. 138.
[28]  Hoa, N., J. Lauritsen, and H. Rieder, Changes in body weight and tuberculosis treatment outcome in Viet Nam. The International Journal of Tuberculosis and Lung Disease, 2013. 17(1): p. 61-66.
[29]  Nissapatorn, V., et al., Tuberculosis in HIV/AIDS patients: a Malaysian experience. 2005.
[30]  Banerjee, A., et al., HIV testing and tuberculosis treatment outcome in a rural district in Malawi. . Transactions of the Royal Society of Tropical Medicine and Hygiene, 1997. 91(6): p. 707-708.
[31]  Chang, J.-T., et al., Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance. Journal of the Formosan Medical Association, 2011. 110(6): p. 372-381.
[32]  32.Nissapatorn, V.e.a., Tuberculosis in Diabetic Patients: A Clinical Perspective. Southeast Asian J Trop Med Public Health 2005. 36 (suppl 4): p. 213-220.
[33]  Diel, R. and S. Niemann, Outcome of tuberculosis treatment in Hamburg: a survey, 1997–2001. The International Journal of Tuberculosis and Lung Disease, 2003. 7(2): p. 124-131.
[34]  Nik, N.R., Mohd, N.S., Wan, M., and Sharina, D., Factors associated with unsuccessful treatment outcome of pulmonary tuberculosis in Kota Bharu, Kelantan. . Malays J Publ Health Med 2011. 11: p. 6-15.
[35]  Commission, N.P., The 2006 Population and Housing Census of the Federal Republic of Nigeria. Priority Tables (Volume I). . Abuja, Nigeria: The National Population Commission, 2009.
[36]  Balasubramanian, R., et al., Gender disparities in tuberculosis: report from a rural DOTS programme in south India. The International Journal of Tuberculosis and Lung Disease, 2004. 8(3): p. 323-332.
[37]  Jimenez-Corona, M.-E., et al., Gender differentials of pulmonary tuberculosis transmission and reactivation in an endemic area. Thorax, 2006. 61(4): p. 348-353.
[38]  Feng, J.Y., et al., Gender differences in treatment outcomes of tuberculosis patients in Taiwan: a prospective observational study. Clinical Microbiology and Infection, 2012. 18(9): p. E331-E337.
[39]  Belo, M.T.C.T., et al., Tuberculosis and gender in a priority city in the state of Rio de Janeiro, Brazil. Jornal Brasileiro de Pneumologia, 2010. 36(5): p. 621-625.
[40]  Kamel, M., et al., Gender differences in health care utilization and outcome of respiratory tuberculosis in Alexandria. 2003.
[41]  Bashour, H. and F. Mamaree, Gender differences and tuberculosis in the Syrian Arab Republic: patients' attitudes, compliance and outcomes. 2003.
[42]  Faustini, A., et al., Treatment outcomes and relapses of pulmonary tuberculosis in Lazio, Italy, 1999–2001: a six-year follow-up study. International Journal of Infectious Diseases, 2008. 12(6): p. 611-621.
[43]  Neyrolles, O. and L. Quintana-Murci, Sexual inequality in tuberculosis. PLoS Med, 2009. 6(12): p. e1000199.
[44]  Calippe, B., et al., Chronic estradiol administration in vivo promotes the proinflammatory response of macrophages to TLR4 activation: involvement of the phosphatidylinositol 3-kinase pathway. The Journal of Immunology, 2008. 180(12): p. 7980-7988.
[45]  Janele, D., et al., Effects of Testosterone, 17β‐Estradiol, and Downstream Estrogens on Cytokine Secretion from Human Leukocytes in the Presence and Absence of Cortisol. Annals of the New York Academy of Sciences, 2006. 1069(1): p. 168-182.
[46]  Flanagan, K.L., Sexual dimorphism in biomedical research: a call to analyse by sex. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2014. 108(7): p. 385-387.
[47]  Antoine, D., et al., Tuberculosis treatment outcome monitoring in England, Wales and Northern Ireland for cases reported in 2001. Journal of epidemiology and community health, 2007. 61(4): p. 302-307.
[48]  Leung, C.C., et al., Smoking adversely affects treatment response, outcome and relapse in tuberculosis. European Respiratory Journal, 2015. 45(3): p. 738-745.
[49]  Zellweger, J.-P., A. Cattamanchi, and G. Sotgiu, Tobacco and tuberculosis: could we improve tuberculosis outcomes by helping patients to stop smoking? European Respiratory Journal, 2015. 45(3): p. 583-585.
[50]  Oshi, S., et al., Investigating gender disparities in the profile and treatment outcomes of tuberculosis in Ebonyi state, Nigeria. Epidemiology and infection, 2015. 143(05): p. 932-942.
[51]  Chan-Yeung, M., et al., Socio-demographic and geographic indicators and distribution of tuberculosis in Hong Kong: a spatial analysis. The International Journal of Tuberculosis and Lung Disease, 2005. 9(12): p. 1320-1326.
[52]  Ebrahimzadeh, A., M. Mohammadifard, and G. Naseh, Comparison of Chest X-Ray Findings of Smear Positive and Smear Negative Patients with Pulmonary Tuberculosis. Iranian Journal of Radiology, 2014. 11(4).
[53]  Scheelbeek, P., et al., Risk factors for poor tuberculosis treatment outcomes in Makassar, Indonesia. The Southeast Asian journal of tropical medicine and public health, 2014. 45(4): p. 853-858.
[54]  Harries, A., et al., Treatment outcome of patients with smear-negative and smear-positive pulmonary tuberculosis in the National Tuberculosis Control Programme, Malawi. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1999. 93(4): p. 443-446.
[55]  Albuquerque, M.d.F.P.M., et al., Factors associated with treatment failure, dropout, and death in a cohort of tuberculosis patients in Recife, Pernambuco State, Brazil. Cadernos de Saúde Pública, 2007. 23(7): p. 1573-1582.
[56]  Atif, M., et al., Treatment outcome of new smear positive pulmonary tuberculosis patients in Penang, Malaysia. BMC infectious diseases, 2014. 14(1): p. 399.
[57]  Talay, F., S. Kumbetli, and S. Altin, Factors associated with treatment success for tuberculosis patients: a single center's experience in Turkey. Japanese journal of infectious diseases, 2008. 61(1): p. 25.
[58]  Bao, Q.-S., Y.-H. Du, and C.-Y. Lu, Treatment outcome of new pulmonary tuberculosis in Guangzhou, China 1993–2002: a register-based cohort study. BMC Public Health, 2007. 7(1): p. 344.
[59]  Redd, J.T. and E. Susser, Controlling tuberculosis in an urban emergency department: a rapid decision instrument for patient isolation. American journal of public health, 1997. 87(9): p. 1543-1547.
[60]  El-Solh, A., et al., Validity of a decision tree for predicting active pulmonary tuberculosis. American journal of respiratory and critical care medicine, 1997. 155(5): p. 1711-1716.
[61]  Mold, J.W., B.J. Holtzclaw, and L. McCarthy, Night sweats: a systematic review of the literature. The Journal of the American Board of Family Medicine, 2012. 25(6): p. 878-893.
[62]  van Crevel, R., et al., Decreased plasma leptin concentrations in tuberculosis patients are associated with wasting and inflammation. The Journal of Clinical Endocrinology & Metabolism, 2002. 87(2): p. 758-763.
[63]  Chou, S.-H.S., et al., Thoracic diseases associated with HIV infection in the era of antiretroviral therapy: clinical and imaging findings. RadioGraphics, 2014. 34(4): p. 895-911.
[64]  Bailey, S.L. and P. Grant, ‘The tubercular diabetic’: the impact of diabetes mellitus on tuberculosis and its threat to global tuberculosis control. Clinical Medicine, 2011. 11(4): p. 344-347.